Odyssey Therapeutics ODTX
NASDAQ ODTX
$19.36 +0.22 (+1.15%)
At close: Nov 16, 2026 · 4:00 PM EST

Odyssey Therapeutics (ODTX) Debt Ratio (2022)

Updated

Odyssey Therapeutics' Debt Ratio came in at 0.02 for Q4 2022.

Analysis

Odyssey Therapeutics (ODTX) Debt Ratio (2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 0.33
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 0.23
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 0.55
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 0.41
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn -0.05
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 0.56
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 0.51
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 0.31
10 Odyssey Therapeutics 929.15 Mn -64.53 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 0.02
API Access

Odyssey Therapeutics Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=ODTX&period=max&api_key=YOUR_API_KEY